Using Metabolic Biomarkers For Monitoring After Transurethral Resection Of Bladder Tumor May Be Feasible, Analysis Suggests.

The Cancer Network (6/22, Levitan) reported researchers have “identified several metabolites and metabolic indicators as potential biomarkers for recurrence risk in non–muscle-invasive bladder cancer (NMIBC).” The Cancers Network adds, “A pilot analysis...